Genotype analysis of severe acute respiratory syndrome coronavirus 2 (covid-19) by nucleic acid for identification of mutations in targeted regions
Medicare pricing data for 34 providers across 4 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Genotype analysis of severe acute respiratory syndrome coronavirus 2 (covid-19) by nucleic acid for identification of mutations in targeted regions (HCPCS code 87913) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $252.25, but hospitals typically charge $481.42 — a 1.9x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $252.25, your out-of-pocket cost would be approximately $50.45. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.9x more than what Medicare allows for this procedure. Medicare actually pays $252.25 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Kentucky | $253 | $400 | 11 | 17 | +0.4% |
| Texas | $252 | $454 | 10 | 45,815 | +0.0% |
| California | $252 | $500 | 2 | 41,857 | +0.0% |
| Illinois | $252 | $500 | 6 | 27,004 | -0.0% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber